InfantRisk Center
Industry-fundedTexas Tech University Health Sciences Center research center and Clinical Research Unit · United States
Visit the source site · Audited 2026-10-14
Who pays for it
InfantRisk advertises pharmaceutical and research partnerships, sponsored studies and consulting, while the Payne Foundation supports its free call center; sponsor-specific payment totals were not found.
Status: Labeled
The Center markets research and consulting to pharmaceutical companies whose products may be assessed, but no sponsor-to-entry link was verified. It is cited with a visible commercial-exposure label and an independent check.
How SafeMomma uses it
We use its medication information only with a visible partnership label and corroboration from a source with different owners and funding.
The audit
- Who controls it
- InfantRisk describes itself as a research center within Texas Tech University Health Sciences Center and its Clinical Research Unit. Its pages identify lactation-pharmacology and research expertise, and name Kaytlin Krutsch as Center director and co-author with Thomas Hale.
- Money
- The Center advertises pharmaceutical partnerships, sponsored study execution, milk analysis, consultation and sponsorship programs. The Payne Foundation is separately credited with supporting the free call center; sponsor payments and links to individual public entries were not verified.
- Conflict rules
- The research page describes IRB and human-subject safeguards under federal rules. The reviewed pages do not provide a public financial conflict policy, sponsor contracts or per-entry sponsor and author disclosures.
- Method
- InfantRisk describes milk-only, milk-and-plasma and mother-infant study designs, along with interventional, observational and consultation work. The page does not explain how commercial studies are separated from public ratings or how each public conclusion is developed.
- Dates on its pages
- The research page has no overall revision date, and a portfolio-wide update schedule or date for every public rating was not established.
- Political exposure
- InfantRisk is university-based, not a government regulator, and operates under federal research and drug-labeling rules. No source-specific political interference or ordered content change was identified.
- Money exposure
- The Center has direct commercial exposure because it offers studies and consulting to drug companies whose products may be assessed. That overlap calls for entry-specific disclosure, but no sponsor-to-entry link or sponsor influence was verified.
- Track record
- The audit found no major correction or retraction record for public ratings in the reviewed materials, but the review was not exhaustive. InfantRisk's own performance claims were not independent validation; none of b1-b5 supplied a source-specific InfantRisk test finding.
Where this comes from
Incentive exposure describes pressure from money or politics, not whether the source is right. Funding alone does not show influence.